The relationship between GSK-3 beta and Drp-1 in alleviating myocardial ischem ia reperfusion injury in rats
LUO Wei-hao1 HE Jian-dong2 HAN Chong-fang2▲
1.Department of Anesthesiology,Shanxi Medical University,Shanxi Province,Taiyuan 030001,China;
2.Department of Anesthesiology,Hospital of Shanxi Medical University,Shanxi Province,Taiyuan 030001,China
Abstract:ObjectiveTo investigate the relationship between GSK-3β and Drp-1 in the myocardium protection in rats.Methods60 healthy male SD rats,weighing 250-300 g,randomly divided into 4 groups (n=15):Ischemia reperfusion group(group IR),Ischemia reperfusion+Mivi-1 treatment group(group M),Ischemia reperfusion+SB216763 treatment group(group B),and Ischemia reperfusion+Mivi-1 treatment group+SB216763 treatment group(group D).The myocardial ischemia-reperfusion injury model was established by ligating the LAD for 30 min and reperfusion for 120 min.Mdivi-1(1.2 mg/kg)was given at 1 min before reperfusion in group M by intravenous injection.SB216763(0.2 mg/kg)was given at 1 min before reperfusion in group B by intravenous injection.Both of them were given at 1 min before reperfusion in group D by intravenous injection.cTnI concentration was detected from abdominal aorta blood.Myocardial specimens were obtained from the apex for determination of the AI by TUNEL.Myocardial pathology were observed and the expression of caspase-3 was detected by Western blot.ResultsCompared with IR group,the levels of caspase-3,AI and myocardial injury in M,B and D groups were down-regulated(P<0.05).Compared with D group,the levels of caspase-3,AI and myocardial injury were increased in M and B group the differences were statistical significant(P<0.05).Conclusion The relationship between GSK-3β and Drp-1 of the myocardium protection in rats is not a single dependency.
罗维昊; 贺建东; 韩冲芳. 糖原合成酶激酶-3与线粒体分裂蛋白在减轻大鼠心肌缺血再灌注损伤作用中的关系[J]. 中国当代医药, 2018, 25(17): 12-15.
LUO Wei-hao;HE Jian-dong;HAN Chong-fang2▲. The relationship between GSK-3 beta and Drp-1 in alleviating myocardial ischem ia reperfusion injury in rats. 中国当代医药, 2018, 25(17): 12-15.
Zhang J,Wang C,Yu S,et al.Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling[J].Sci Rep,2014,4:7317.
Smillie KJ,Cousin MA.Akt/PKB controls the activity-dependent bulk endocytosis of synaptic vesicles[J].Traffic,2012,13(7):1004-1011.
[12]
Zhang Y,Babcock SA,Hu N,et al.Mitochondrial aldehyde dehydrogenase(ALDH2)protects against streptozotocin-induced diabetic cardiomyopathy:role of GSK3beta and mitochondrial function[J].BMC Med,2012,10:40.
[13]
Brooks MM,Neelam S,Fudala R,et al.Lenticular mitoprotection.Part A:monitoring mitochondrial depolarization with JC-1 and artifactual fluorescence by the glycogen synthase kinase-3beta inhibitor,SB216763[J].Mol Vis,2013,19:1406-1412.
[14]
Clayton EL,Sue N,Smillie KJ,et al.Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles[J].Nat Neurosci,2010,13(7):845-851.
[15]
Liu H,Peng H,Chen S,et al.S1PR2 antagonist protects endothelial cells against high glucose-induced mitochondrial apoptosis through the Akt/GSK-3beta signaling pathway[J].Biochem Biophys Res Commun,2017,490(3):1119-1124.
[16]
Lumetti S,Calciolari E,Parisi L,et al.Study of GSK3b inhibitors SB415286 and SB216763 to improve osteoblastic differentiation on microstructured titanium[J].J Biol Regul Homeost Agents,2017,31(3):579-587.
[18]
D'Urzo A,De Simone A,Fiori J,et al.D IRect determination of GSK-3beta activity and inhibition by UHPLC-UV-vis diode arrays detector(DAD)[J].J Pharm Biomed Anal,2016,124:104-111.
[19]
Hibbert B,Lavoie JR,Ma X,et al.Glycogen synthase kinase-3beta inhibition augments diabetic endothelial progenitor cell abundance and functionality via cathepsin B:a novel therapeutic opportunity for arterial repa IR[J].Diabetes,2014,63(4):1410-1421.
[20]
Gao D,Yang J,Wu Y,et al.Targeting dynamin 2 as a novel pathway to inhibit cardiomyocyte apoptosis following oxidative stress[J].Cell Physiol Biochem,2016,39(6):2121-2134.